Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
72.61B | 74.74B | 66.10B | 66.13B | 61.53B | Gross Profit |
75.25B | 74.74B | 66.10B | 66.13B | 61.53B | EBIT |
16.23B | 11.81B | 10.33B | 10.08B | 5.83B | EBITDA |
20.16B | 19.28B | 16.51B | 15.51B | 11.60B | Net Income Common Stockholders |
11.26B | 10.87B | 9.00B | 8.02B | 8.07B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
230.92B | 484.39B | 790.92B | 739.97B | 374.69B | Total Assets |
5.40T | 5.33T | 5.49T | 5.32T | 4.67T | Total Debt |
70.92B | 133.58B | 397.78B | 349.94B | 43.35B | Net Debt |
-230.92B | -350.81B | -393.14B | -390.03B | -331.33B | Total Liabilities |
5.13T | 86.67B | 5.24T | 5.07T | 4.44T | Stockholders Equity |
274.10B | 252.88B | 250.52B | 249.15B | 235.43B |
Cash Flow | Free Cash Flow | |||
-33.09B | -227.94B | 110.83B | 417.07B | 22.04B | Operating Cash Flow |
-29.68B | -225.62B | 124.33B | 425.70B | 30.71B | Investing Cash Flow |
-219.48B | -77.62B | -70.81B | -57.73B | 9.44B | Financing Cash Flow |
43.88B | -3.24B | -2.66B | -2.69B | -2.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $862.50B | 12.91 | 5.72% | 3.12% | 9.55% | 9.39% | |
71 Outperform | ¥298.95B | 9.29 | 2.05% | 21.04% | 20.47% | ||
70 Outperform | ¥698.06B | 11.49 | 6.00% | 3.49% | 15.35% | -1.62% | |
70 Neutral | ¥99.45B | 7.63 | 3.99% | -1.59% | 20.55% | ||
64 Neutral | $12.64B | 9.74 | 8.05% | 17044.60% | 12.66% | -4.62% |